首页 | 本学科首页   官方微博 | 高级检索  
检索        

抗类风湿关节炎中药经皮给药制剂研究进展
引用本文:贾成友,张传辉,李微,赵凤平,杨荣平,王云红.抗类风湿关节炎中药经皮给药制剂研究进展[J].中国实验方剂学杂志,2015,21(16):226-230.
作者姓名:贾成友  张传辉  李微  赵凤平  杨荣平  王云红
作者单位:成都中医药大学 药学院, 成都 611137;重庆市中药研究院, 重庆 400065,成都中医药大学 药学院, 成都 611137;重庆市中药研究院, 重庆 400065,成都中医药大学 药学院, 成都 611137;重庆市中药研究院, 重庆 400065,成都中医药大学 药学院, 成都 611137;重庆市中药研究院, 重庆 400065,成都中医药大学 药学院, 成都 611137;重庆市中药研究院, 重庆 400065,重庆市中药研究院, 重庆 400065
基金项目:中国中医科学院基本科研业务费自主选题项目(2011xyc2-05)
摘    要:类风湿关节炎(RA)是一种慢性、全身性自身免疫性疾病,发病率高、致残率大,是威胁人类健康和生活的重大疾病之一。目前尚无特效药物,临床上多以非甾体抗炎药、抗类风湿性药及糖皮质激素类药用于RA的治疗,但用药过程中多伴有强烈不良反应,患者顺应性较差。中药具有多成分、多靶点作用,在此基础上开发出的中药经皮给药制剂具有给药次数少、患者依从性高、可有效避免食物对药物的影响的特点,且使用方便安全、可随时中断用药。中药经皮给药制剂因其独特的治疗效果及剂型优势已成为研究的热点。本文以治疗RA的中药经皮给药制剂为出发点,评述与探讨其研究的必要性、研究现状及存在问题,提出应着重加强物质基础研究、应保证良好的制剂质量控制、应加强外用辅料研究和传统中药外用制剂机制的研究、加强中药促渗剂科学使用研究等建议,为RA中药经皮给药系统的研究与开发提供参考。

关 键 词:类风湿关节炎  中药  经皮给药
收稿时间:2014/10/20 0:00:00

Research Progress in Transdermal Drug Delivery System of Traditional Chinese Medicine on Rheumatoid Arthritis
JIA Cheng-you,ZHANG Chuan-hui,LI Wei,ZHAO Feng-ping,YANG Rong-ping and WANG Yun-hong.Research Progress in Transdermal Drug Delivery System of Traditional Chinese Medicine on Rheumatoid Arthritis[J].China Journal of Experimental Traditional Medical Formulae,2015,21(16):226-230.
Authors:JIA Cheng-you  ZHANG Chuan-hui  LI Wei  ZHAO Feng-ping  YANG Rong-ping and WANG Yun-hong
Institution:College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China;Chongqing Academy of Chinese Traditional Materia Medica, Chongqing 400065, China,College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China;Chongqing Academy of Chinese Traditional Materia Medica, Chongqing 400065, China,College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China;Chongqing Academy of Chinese Traditional Materia Medica, Chongqing 400065, China,College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China;Chongqing Academy of Chinese Traditional Materia Medica, Chongqing 400065, China,College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China;Chongqing Academy of Chinese Traditional Materia Medica, Chongqing 400065, China and Chongqing Academy of Chinese Traditional Materia Medica, Chongqing 400065, China
Abstract:Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease with a high incidence and disability rate.Currently,RA is deemed as one of major diseases threatening human health and life,but with no effective drug.In clinic,common drugs for RA included nonsteroidal anti-inlammatory drugs,disease modifying antirheumatic drugs and corticosteroids clinically.However,they have severe adverse reactions,which bring great pains to patients.Traditional Chinese medicine (TCM) feature multiple components and multiple-target effect,based on which TCM transdermal drug delivery preparations have advantages of low medicinal frequency,high compliance among patients,effective reduction of foods' impacts on drugs,convenience,safety and drug withdrawal at anytime.Transdermal drug delivery preparations have become a hotspot of studies because of their unique therapeutic effect and formulation superiority.In this dissertation,authors evaluated and discussed necessity,current situation and existing problems of TCM transdermal drug delivery preparations,and gave their own suggestions,such as strengthen the material base studies,ensure a good quality control of preparation,strengthen studies on the external excipients and the mechanism of external TCM preparations,strengthen the studies on the scientific use of TCM penetration enhancer,in expectation of providing a reference for research and development of TCM transdermal drug delivery system.
Keywords:rheumatoid arthritis  traditional Chinese medicine  transdermal delivery
本文献已被 CNKI 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号